Publication date: May 12, 2019
When diagnosed at stage 0-I, melanoma has a 5-year survival rate of 92% to 100% in comparison with stage IV, which has a 5-year survival rate of 15% to 20%.
The objective of this article is to identify what socioeconomic and demographic factors were associated with increased odds in receiving a delayed melanoma diagnosis.
This study analyzed the odds of 108,628 patients from the National Cancer Database who were diagnosed between 2004 and 2012 with American Joint Committee on Cancer stage 0-I and stage IV based on race, sex, insurance type, income, facility type, and education.
We identified significantly ( P
Dick, M., Aurit, S., and Silberstein, P. The Odds of Stage IV Melanoma Diagnoses Based on Socioeconomic Factors. 22601. 2019 J Cutan Med Surg.
|Insurance||Five-year survival rate|
- Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.